TerrAscend (TSNDF) Gains from Investment Securities (2021 - 2025)
TerrAscend (TSNDF) posted quarterly Gains from Investment Securities of -$179000.0 for Q4 2025, up 83.46% year-over-year from -$97570.8 in Q4 2024, and up 84.71% quarter-over-quarter from -$1.2 million in Q3 2025.
TerrAscend (TSNDF) Gains from Investment Securities (2021 - 2025) Analysis & Trends
TerrAscend (TSNDF) has reported Gains from Investment Securities for 5 consecutive years, with -$179000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Gains from Investment Securities rose 83.46% year-over-year to -$179000.0; the TTM figure through Mar 2026 stood at -$1.4 million (down 195.25% YoY), while the FY2025 annual figure was -$1.0 million, down 140.73% from the prior year.
- Gains from Investment Securities improved to -$179000.0 in Q4 2025 per TSNDF's latest filing, from -$1.2 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $3.0 million in Q1 2021 and bottomed at -$1.2 million in Q4 2022.
- Historically, Gains from Investment Securities has averaged $196470.6 across 5 years, with a median of $34000.0 in 2022.
- Annual changes were most pronounced in 2022 — Gains from Investment Securities soared 585.71% — and 2023, when it sank 1891.67%.
- TerrAscend's Gains from Investment Securities stood at $932000.0 in 2021, then tumbled by 234.12% to -$1.2 million in 2022, then soared by 48.4% to -$645000.0 in 2023, then sank by 67.75% to -$1.1 million in 2024, then soared by 83.46% to -$179000.0 in 2025.
- Business Quant data shows TSNDF's Gains from Investment Securities at -$179000.0 in Q4 2025, -$1.2 million in Q3 2025, and -$34000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | TerrAscend | 182.53 Mn | 140.41 Mn | 36.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -179,000.00 |
| Dec 31, 2025 | -179,000.00 |
| Sep 30, 2025 | -1.17 Mn |
| Sep 30, 2025 | -1.17 Mn |
| Jun 30, 2025 | -34,000.00 |
| Jun 30, 2025 | -34,000.00 |
| Mar 31, 2025 | 381,000.00 |
| Mar 31, 2025 | 381,000.00 |
| Dec 31, 2024 | -1.08 Mn |
| Dec 31, 2024 | -1.08 Mn |
| Sep 30, 2024 | 327,000.00 |
| Sep 30, 2024 | 327,000.00 |
| Jun 30, 2024 | 1.83 Mn |
| Jun 30, 2024 | 1.83 Mn |
| Mar 31, 2024 | 1.39 Mn |
| Mar 31, 2024 | 1.39 Mn |
| Sep 30, 2023 | -645,000.00 |
| Sep 30, 2023 | -645,000.00 |
| Dec 31, 2022 | -1.25 Mn |
| Dec 31, 2022 | -1.25 Mn |